2.8800.52% ( +0.015 )
Delay Closed: Nov 17, 16:08:15Shareholders
All Shareholders
Shareholder Type
- Public and others63.70%
- Individuals & Insiders16.41%
- ESOPs10.64%
- VC/PE firms8.47%
- Institutions0.78%
Major Shareholders
| Shareholder | |||||
|---|---|---|---|---|---|
Wenzhi TianFounder, CEO, Chief Scientific Officer & Chairman of the Board | 16.41% | 70.48M | 0.09% | +50.00K | |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP | 10.64% | 45.70M | 0.05% | +0 | |
Shanghai Yongkan Investment Management Co., Ltd. | 8.47% | 36.39M | 0.04% | +0 | |
GF Fund Management Co., Ltd. | 0.76% | 3.28M | <0.01% | +0 | |
Fullgoal Fund Management Co. Ltd. | 0.02% | 88.60K | <0.01% | +0 | |
Dimensional Fund Advisors LP | 0.00% | 0.00 | <0.01% | -18.80K | |
State Street Investment Management | 0.00% | 0.00 | 0.22% | -939.20K |
